About: Efficacy and Safety of SPD503 in Combination With Psychostimulants

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy and Safety of SPD503 in Combination With Psychostimulants Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Efficacy and Safety of SPD503 in Combination With Psychostimulants (en)
skos:prefLabel	Efficacy and Safety of SPD503 in Combination With Psychostimulants (en)
name	Efficacy and Safety of SPD503 in Combination With Psychostimulants (en)
title	wds:Q63063555-88EC6A4F-7B37-4CEA-834B-9B33C54D72DA
title	A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose Optimization Study Evaluating the Efficacy and Safety of SPD503 in Combination With Psychostimulants in Children and Adolescents Aged 6-17 Years With a Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) (en)
end time	wds:Q63063555-13ECBCAB-87D5-4B14-8E58-F4873DDED3B6
end time	2009-12-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q63063555-B9D0901B-45B7-4678-8774-D4F7562DDA0C
instance of	clinical trial
start time	wds:Q63063555-5364F474-465B-4308-B78B-DD72FF0D840A
start time	2008-09-01 00:00:00Z (xsd:dateTime)
country	wds:Q63063555-11E43EAB-5DA4-4177-B225-54E01E076D79
country	United States of America
research site	wds:Q63063555-50A24F88-B277-4362-A4A6-2024C7FC012E wds:Q63063555-6C28E22E-BACA-4258-B114-B783E9D72E68 wds:Q63063555-A09976AC-4789-4E53-B081-30B03327F21E wds:Q63063555-AEE1F0AF-F296-4751-93CC-00226B89975A wds:Q63063555-B4375750-8651-4C1E-B62E-E3217850ED01 wds:Q63063555-F1FD9802-0B6F-4AD9-906E-72D6355123BB wds:Q63063555-F2064768-CA62-4996-A063-2E06C4354635 wds:Q63063555-FC3DF65C-3DAA-40CF-997B-3207906BE090
research site	University of California, San Francisco Case Western Reserve University Children's Specialized Hospital Northwest Clinical Research Center Rochester Center for Behavioral Medicine Gulfcoast Clinical Research Center Meridien Research Summit Research Network
research intervention	wds:Q63063555-CC5E533A-FDE0-4652-A076-BB596FCE02FE
research intervention	guanfacine
minimum age	wds:Q63063555-B9B0C2C9-2204-411A-AEA6-B5482A8F0903
minimum age	6 (xsd:decimal)
sponsor	wds:Q63063555-D3A9EB4C-7C7C-403A-8594-19968241AD85
sponsor	Shire plc
number of participants	wds:Q63063555-D7B9E6C6-F98D-428C-AFE6-26F2B48543F1
number of participants	461 (xsd:decimal)
maximum age	wds:Q63063555-B53E9E98-6793-4C3E-AFF8-B871A636A60A
maximum age	17 (xsd:decimal)
study type	wds:Q63063555-7D45F322-8D53-4882-924A-81C0C8B9C761
study type	interventional study
ClinicalTrials.gov ID	wds:Q63063555-21B6BC88-33FD-4DFC-8724-8EA2620D6369
ClinicalTrials.gov ID	NCT00734578
clinical trial phase	wds:Q63063555-388627A5-DF60-47D5-8B73-56AC6EC077DA
clinical trial phase	phase III clinical trial
research subject recruitment status	wds:Q63063555-C493D750-9150-4B5D-9646-84B007E68BB2
research subject recruitment status	completed
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63063555

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software